ArticleMolecular microbiology2010
A processive riboantiterminator seeks a switch to make biofilms.
Article in Molecular microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- What Is in a Cat Scratch? Growth ofMicroorganisms · 2021Review
- A Two-Way Street: Regulatory Interplay between RNA Polymerase and Nascent RNA Structure.Trends in biochemical sciences · 2016Review
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Since the discovery of the first signal-sensing RNA structure by Grundy and Henkin in 1993, the list of cis-acting riboregulators has grown dramatically. Riboswitches fold into elaborate structures and respond to binding of small metabolites by altering the folding pattern of the surrounding transcript, thereby altering the gene expression programme. Riboswitches that use short-range mechanisms to control transcription attenuation and translation initiation and mediate mRNA cleavage have been characterized in many Gram-positive bacteria. Their action typically relies on alternative RNA structures that are differentially stabilized by the ligand binding. In this issue of Molecular Microbiology, Irnov and Winkler describe a novel Bacillus subtilis riboregulator called EAR that shares structural complexity with riboswitches but possesses a unique mechanism of action. EAR increases expression of exopolysaccharide genes and biofilm formation, and appears to act as a processive, long-range antiterminator, the first such example outside of Escherichia coli. While it is unclear whether EAR senses a biofilm-inducing signal, the results suggest that its action depends on yet unidentified auxiliary factors. Interestingly, efficient capsule biogenesis in E. coli and Bacteroides fragilis also depends on processive antiterminators but utilizes the protein-based mechanisms instead.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.